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Question: Does supervised physical activity reduce cancer-related fatigue? Design: Systematic review
with meta-analysis of randomised trials. Participants: People diagnosed with any type of cancer,
without restriction to a particular stage of diagnosis or treatment. Intervention: Supervised physical
activity interventions (eg, aerobic, resistance and stretching exercise), deﬁned as any planned or
structured bodymovement causing an increase in energy expenditure, designed to maintain or enhance
health-related outcomes, and performed with systematic frequency, intensity and duration. Outcome
measures: The primary outcome measure was fatigue. Secondary outcomes were physical and
functional wellbeing assessed using the Functional Assessment of Cancer Therapy Fatigue Scale,
European [3_TD$DIFF]Organisation for Research and Treatment of Cancer Quality of Life Questionnaire, Piper Fatigue
Scale, Schwartz Cancer Fatigue Scale and the Multidimensional Fatigue Inventory. Methodological
quality, including risk of bias of the studies, was evaluated using the PEDro Scale. Results: Eleven studies
involving 1530 participants were included in the review. The assessment of quality showed amean score
of 6.5 (SD 1.1), indicating a low overall risk of bias. The pooled effect on fatigue, calculated as a
standardised mean difference (SMD) using a random-effects model, was –1.69 (95% CI –2.99 to –0.39).
Beneﬁcial reductions in fatigue were also found with combined aerobic and resistance training with
supervision (SMD = –0.41, 95% CI –0.70 to –0.13) and with combined aerobic, resistance and stretching
trainingwith supervision (SMD = –0.67, 95% CI –1.17 to –0.17). Conclusion: Supervised physical activity
interventions reduce cancer-related fatigue. These ﬁndings suggest that combined aerobic and
resistance exercise regimens with or without stretching should be included as part of rehabilitation
programs for people who have been diagnosed with cancer. Registration: PROSPERO CRD42013005803.
[Meneses-Echa´vez JF, Gonza´lez-Jime´nez E, Ramı´rez-Ve´lez R (2015) Supervised exercise reduces
cancer-related fatigue: a systematic review. Journal of Physiotherapy 61: 3–9]
 2014 Australian Physiotherapy Association. Published by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The number of people diagnosed worldwide with cancer has
been estimated to be as high as 10million, with another 25million
having survived cancer.1 In Colombia, the National Cancer Institute
reported that malignant tumours are the third biggest cause of
mortality, increasing their mortality burden from 6 [5_TD$DIFF]to 15% in the
six decades before 2002.2 This increase in cancer diagnoses is an
important public health problem, with the number of new cases
diagnosed in 2020 expected to be approximately 1.7 million.3
Cancer-related fatigue is a common problem for people with
cancer. Approximately 80 to 100% of peoplewith cancer report that
they experience cancer-related fatigue.4 Furthermore, many
people continue to experience fatigue for months or years after
successful treatment.4 Several concepts of cancer-related fatigue
have been published in the biomedical literature. Stone and
colleagues found that 75% of [6_TD$DIFF]people with various solid tumours
(among whom 48 out of 95 had metastatic disease) had a
signiﬁcantly increased cancer-related fatigue score comparedwith
a matched control population.4 The Colombian National Cancer
Institute2 and the National Comprehensive Cancer Network5
deﬁne cancer-related fatigue as ‘a distressing, persistent, subjec-
tive sense of physical, emotional and/or cognitive tiredness orhttp://dx.doi.org/10.1016/j.jphys.2014.08.019
1836-9553/ 2014 Australian Physiotherapy Association. Published by Elsevier B
creativecommons.org/licenses/by-nc-nd/3.0/).exhaustion related to cancer or cancer treatment that is not
proportional to recent activity and interferes with usual function-
ing’. Cancer-related fatigue also has a severe impact on daily
activities, social relationships, reintegration and overall quality of
life.6 Some evidence suggests that cancer-related fatigue may be a
predictor of survival for people with cancer.7
Physical activity has been proposed as an effective non-
pharmacologic intervention to promote psychological wellbeing
during and following cancer treatment.8 A growing body of
evidence indicates that physical activity improves muscle strength
and body composition in people with cancer.9,10 Recent systematic
reviews examining the effect of physical activity on psychological
and functional outcomes have tended to study particular types of
cancer instead of all cancer types, with lung and breast cancer
being the most widely studied.11–13 A recent Cochrane systematic
review14 about exercise and cancer-related fatigue concluded that
aerobic exercise reduces cancer-related fatigue and encouraged
further research of other exercise modalities; however, this review
only included data published before March 2011 and did not
examine supervised physical activity interventions in isolation
from unsupervised interventions.
Supervision plays an important role in the effects of exercise
interventions in chronically ill people.15,16 This value of supervision.V. This is an open access article under the CC BY-NC-ND license (http://
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perhaps because of greater encouragement or conﬁdence to work
when the help of a health professional is at hand. A supervising
health professional may also help to individualise the exercise
regimen to the speciﬁc condition of the person, such as the complex
sequelae of cancer and its treatment.17,18 Whitehead and Lavel-
leand19 and Spence et al20 reported that breast and colon cancer
survivors prefer supervised exercise training over unsupervised
exercise. In light of this, Lin et al21 compared the effects of a
supervised exercise intervention with those of usual care for
12 weeks in colorectal cancer patients during chemotherapy, and
found signiﬁcant improvements in the supervised exercise groupon
fatigue, physical activity[7_TD$DIFF], physical functioning, social functioning,
hand-grip strength, cardiorespiratory ﬁtness, and pain subscales of
quality of life. Similarly, in a sample of 113 breast cancer patients,
Schneider et al18 reported that moderate-intensity individualised
exercise improvedcardiopulmonary functionandfatigueduringand
after treatment. This apparent value of supervision and the lack of
subgroup analysis of supervised physical activity interventions in
isolation from unsupervised interventions in previous reviews
necessitated a systematic review to determine the effectiveness
of supervised physical activity. The current systematic review
therefore aimed to answer two questions:1. Does supervised physical activity improve cancer-related
fatigue and physical and functional wellbeing among people
with current or previous cancer?2. What are the effects of speciﬁcmodalities of supervised physical
activity on these outcomes among people with current or
previous cancer?Methods
This systematic review was conducted according to the
Cochrane Handbook for Systematic Reviews of Interventions,22
analysed using Review Manager Software version 5.2,23 and
reported according to the PRISMA statement.24
Identiﬁcation and selection of studies
Four electronic databases were searched (PubMed, CENTRAL,
EMBASE and OVID) to September 2013. The search strategy
incorporated the recommendations for a highly sensitive search
strategy for the retrieval of clinical trials on PubMed.25 The ﬁnal
search strategy followed the format: (randomized controlled trialOR
controlled clinical trial OR randomized OR trial OR ‘‘clinical trials as
topic’’) AND (cancerORneoplasm* OR tumour* OR tumor* OR carcino*
OR leukaemi* OR leukemi*) AND (physical activity OR exercise OR
aerobic OR resistance OR strength OR ﬂexibility OR stretching) AND
(fatigue). See Appendix 1 [8_TD$DIFF]on the eAddenda for further details of
search strategy.
Two authors (JFM-E and RR-V) independently reviewed all of
the retrieved studies against the [9_TD$DIFF]inclusion criteria (Box 1). The titleBox 1. Inclusion [4_TD$DIFF]criteria.
Design
 Randomised controlled trial
Participants
 Patients with any type of cancer, without restriction to a
particular stage of diagnosis or treatment
Intervention
 Supervised physical activity interventions (aerobic,
resistance or stretching)
Outcome measures
 Cancer-related fatigue (primary outcome)
 Physical wellbeing
 Functional wellbeing
Comparisons
 Supervised physical activity versus conventional careand abstract were examined and full text was obtained if therewas
ambiguity regarding eligibility. When the two authors could
not reach an agreement, a third author [10_TD$DIFF]arbitrated in cases of
disagreement (EG-J). Additionally, the authors searched for other
[11_TD$DIFF]relevant trials listed in the reference lists of the retrieved articles,
and [12_TD$DIFF]in journals specialised in oncology for other possible relevant
trials (ie, Cancer, Journal of Clinical Oncology, Breast Cancer Research,
Journal of Oncology Practice and The Lancet Oncology). No language
restrictions were applied.
Assessment of the characteristics of the studies
Quality
Themethodological quality of the studies including their risk of
bias was assessed using the Physiotherapy Evidence Database
(PEDro) scale.26 The PEDro scale rates the methodological quality
of randomised trials out of 10. A trained assessor determined the
score for each included study (JFM-E). Scores were based on all
information available from both the published version and from
communication with the authors. A score of 5 out of 10 was set as
the minimum score for inclusion in the review.
Participants
This systematic review included studies involving people
diagnosed with any type of cancer, without restriction to a
particular stage of diagnosis or treatment. Participants may have
received active treatment regardless of therapeutic approach (eg,
chemotherapy, radiotherapy).
Intervention
The experimental intervention was supervised physical activity.
[13_TD$DIFF]Physical activity was considered as any body movement causing an
increase in energy expenditure, and involving a planned or
structured movement of the body performed in a systematic
manner in terms of frequency, intensity, and duration and is
designed to maintain or enhance health-related outcomes.27 [14_TD$DIFF] he
control intervention was sham or conventional care. Physical
activity interventions [15_TD$DIFF]such as aerobic, resistance and/or stretching
training were included. All interventions had to be supervised by
health professionals; therefore, home-based physical activity,
telephone monitoring and cognitive approaches were excluded
from the analysis. Yoga and Tai Chi interventions were not included
due to excessive variation in their mode, frequency, duration and
intensity. [16_TD$DIFF]Subgroup analysis was performed to explore the speciﬁc
effect of supervised physical activity modalities (ie, aerobic,
resistance and stretching training). The pooled statistical analysis
and effect size was calculated for each physical activity training
modality.
Outcome measures
The primary outcome measure was cancer-related fatigue
measured using the Functional Assessment of Cancer Therapy
(FACT)-Fatigue Scale, European [3_TD$DIFF]Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-
C30), Piper Fatigue Scale (PFS), Schwartz Cancer Fatigue Scale
(SCFS) and the Multidimensional Fatigue Inventory (MFI). The
secondary outcomes were physical and functional wellbeing
measured with the EORTC QLQ-C30 and FACT, and adverse events.
Data analysis
Relevant data were extracted independently from the eligible
trials by two reviewers (JFM-E and RR-V) using a standard form,
and the third author (EG-J) arbitrated in cases of disagreement. The
reviewers extracted information about the methods (ie, design,
participants and intervention) and the outcome data for the
experimental and control groups. A random-effects model was
used when there was substantial heterogeneity (I2 > 50%).
Continuous outcomes were reported as standardised mean
[(Figure_1)TD$FIG]
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Figure 1. Flow of studies through the review.
Research 5differences (SMD) with 95% CI, with statistical signiﬁcance set at a
p-value < 0.05.
Results
Flow of trials through the review
Eleven randomised controlled trials involving 1530 participants
were included (Figure 1).28–38 The majority of studies were
conducted in Canada (n = 4, 36%), Australia (n = 2, 18%) and UK
(n = 2, 18%).
Characteristics of the included studies
Quality
The assessment of risk of bias showed amean PEDro score of 6.5
(SD 1.1), indicating consistent methodological quality and a low
risk of most biases except blinding (Table 1).
Participants
The mean age of participants in the included studies ranged
from47 to 66 years.Most participantswere female (n = 1192, 78%).
All participants were receiving treatment at the time of the study
interventions and the most frequent treatment procedure was
chemotherapy (n = 1028). The average time since cancer diagnosis
was 8 months (SD 11). Breast cancer was the most investigatedTable 1
PEDro Scale scores for the included trials (n=11).
Study Random
allocation
Concealed
allocation
Groups
similar at
baseline
Participant
blinding
Therapist
blinding
Assesso
Blindin
Adamsen28 Y Y Y N N N
Campbell29 Y N Y N N N
Courneya30 Y Y Y N N Y
Courneya31 Y Y Y N N N
Dimeo32 Y Y Y N N N
Galva˜o33 Y Y Y N N N
Milne34 Y Y Y N N N
Mutrie35 Y Y Y N N Y
Saarto36 Y N Y N N N
Segal37 Y N Y N N N
Segal38 Y Y Y N N N
N=No, Y=Yes, PEDro=Physiotherapy Evidence Database.cancer type (six trials, 55%),29,30,34–37 followed by prostate cancer
(two trials, 18%),33,38 and lymphoma (one trial, 9%).31 Two trials
(18%) included diverse types of cancer.28,32
Interventions
The interventions had a mean duration of 17 weeks (SD 12)
with an average of three sessions (SD 1) per week. The mean
session duration was 45 minutes (SD 29). The interventions
included aerobic exercise (ie, walking and stationary cycling) in
all trials, resistance training in six trials (55%) and stretching/
ﬂexibility exercises in four trials (36%). Training intensity varied
considerably among studies, ranging from 50 to 90% maximum
heart rate. All studies reported pre-exercise screening before high-
intensity physical training. Table 2 summarises the characteristics
of the included studies.
Outcome measures
The primary outcome – cancer-related fatigue – was measured
using the FACT-Fatigue Scale in 55% of the included trials, the
EORTC QLQ-C30 in 36% of trials, the PFS in 9% and the SCFS in 9%.
Effect of intervention
Primary outcome
Data from all of the included trials were used in the meta-
analysis of the primary outcome.28–38 The pooled SMD was –1.69
(95% CI –2.99 to –0.39), indicating a moderate reduction in fatigue
from supervised physical activity (Figure 2, see Figure 3 on the
eAddenda for a detailed forest plot). Due to considerable statistical
heterogeneity [17_TD$DIFF](p < 0.001, I2 = [18_TD$DIFF]99%), this result was calculated using
a random-effects model[19_TD$DIFF], whichwasmostly due to a single outlying
trial.36
Secondary outcomes
Physical wellbeing was reported in seven studies.28,30,32–35,37
The pooled effect was not statistically signiﬁcant (SMD = 0.27 in
favour of exercise, 95% CI –0.19 to 0.74), with considerable
statistical heterogeneity (p < 0.001, I2 = 88%). Functional wellbeing
was reported in six studies.28,32,32–35 The pooled effect was not
statistically signiﬁcant (SMD = 0.47 in favour of exercise, 95% CI
0.00 to 0.95), again with considerable statistical heterogeneity
(p < 0.001, I2 = 87%).
Three studies (27%) reported adverse events related to super-
vised physical activity interventions. Courneya et al30 reported ﬁve
adverse events in the exercise group ([20_TD$DIFF]lymphoedema, gynaecologic
complaintsand inﬂuenza)and two inthecontrol group(foot fracture
and bronchitis). Courneya et al31 reported one case each of back, hip
and knee pain in the exercise group only. Segal et al38 reported
adverse events related to exercise: chest pain during resistance
training (cardiologic investigations were negative), a syncopal
episode before a treadmill exercise test in the aerobic group (no
cause was identiﬁed), and a myocardial infarction 15minutes after
an exercise session in the aerobic group (full recovery).r
g
< 15%
dropouts
Intention-to-treat
analysis
Between-group
difference
reported
Point estimate
and variability
reported
Total
(0 to 10)
Y Y Y Y 7
Y N Y Y 5
Y Y Y Y 8
Y Y Y Y 7
Y N Y Y 6
Y Y Y Y 7
Y Y Y Y 7
Y Y Y Y 8
Y N Y Y 5
N Y Y Y 5
Y Y Y Y 7
Table 2
Characteristics of the included trials (n =11).
Study Cancer type
[1_TD$DIFF]Cancer treatment
Participants Interventiona Outcome measures
Adamsen28 Mixed types of cancer
Chemotherapy
n=235 (171 female)
Exp: n=118, age (yr) =47 (SD 11)
Con: n=117, age (yr) =47 (SD 11)
Exp: aerobic, resistance and stretching; 120min x
5/wk x 6 wk; intensity 85 to 95%
Con: conventional care
EORTC QLQ-C30, MOS SF-36,
Leisure Time Physical Activity
Questionnaire, 1RM
Campbell29 Breast: early stage (I-II)
Chemotherapy,
radiotherapy
n=22 (22 female)
Exp: n=12, age (yr) =48 (SD 10)
Con: n=10, age (yr) =47 (SD 5)
Exp: aerobic and resistance; 20min x 2/wk x
12 wk; intensity 60 to 75%
Con: conventional care
FACT-G, FACT-B, SWLS, PFS,
SPAQ, 12-minute walk test
Courneya30 Breast: early stage
Chemotherapy,
radiotherapy
n=52 (52 female)
Exp: n=24, age (yr) =59 (SD 5)
Con: n=28, age (yr) =58 (SD 6)
Exp: aerobic; 35min x 3/wk x 15 wk; intensity
70 to 75%
Con: conventional care
FACT- G, FACT-B, FACT-F
Courneya31 Lymphoma: stages I-IV;
Hodgkin’s (18%) and
non-Hodgkin’s (82%)
Chemotherapy
n=122 (72 male)
Exp: n=60, age (yr) =53
(range 18 to 77)
Con: n=62, age (yr) =54
(range 18 to 80)
Exp: aerobic; 45min x 3/wk x 12 wk; intensity
60 to 75%
Con: conventional care
FACT-G, FACT-F
Dimeo32 Mixed: tumour stages I-IV
Chemotherapy,
radiotherapy
n=69 (49 male)
Exp: n=34, age (yr) =55 (SD 10)
Con: n=35, age (yr) =60 (SD 10)
Exp: aerobic; 30min x 5/wk x 3 wk; intensity
80%
Con: progressive relaxation training; 45min
x 3/wk x 3 wk
EORTC QLQ-C30
Galva˜o33 Prostate: localised (93%),
nodal metastases (7%)
Chemotherapy,
radiotherapy
n=57 (57 male)
Exp: n=29, age (yr) =54 (SD 9)
Con: n=28, age (yr) =52 (SD 12)
Exp: aerobic, resistance, stretching; 20min x 2/wk
x 12 wk; intensity 60 to 80%
Con: conventional care
EORTC QLQ-C30, MOS SF-36,
DEXA, 1 RM
Milne34 Breast: early stage
Chemotherapy,
radiotherapy
n=58 (58 female)
Exp: n=29, age (yr) =55 (SD 8)
Con: n=29, age (yr) =55 (SD 8)
Exp: aerobic, resistance, stretching; 30min x 3/wk
x 12 wk; intensity 75%
Con: delayed the same exercise program until
week 13
FACT-B, SCFS, PARQ, Aerobic
Power Index
Mutrie35 Breast: early stage
Chemotherapy,
radiotherapy
n=174 (174 female)
Exp: n=82, age (yr) =51 (SD 10)
Con: n=92, age (yr) =52 (SD 9)
Exp: aerobic, resistance; 45min x 2/wk x 12 wk;
intensity 50 to 75%
Con: conventional care
FACT-G, FACT-B, FACT-F, BDI,
PANAS, SPAQ Leisure time, BMI,
12-min walk test
Saarto36 Breast: early stage
Chemotherapy,
radiotherapy
n=500 (500 female)
Exp: n=263, age (yr) =52
(range 36 to 68)
Con: n=237, age (yr) =52
(range 35 to 68)
Exp: aerobic; 60min x 1/wk x 48 wk; intensity
86 to 92%
Con: encouragement to maintain their previous
level of physical activity and exercise habits
EORTC QLQ-C30, FACIT-F, RBDI,
WHQ
Segal37 Breast: early stage
Chemotherapy
n=123 (123 female)
Exp: n=42, age (yr) =51 (SD 9)
Con1: n=41, age (yr) =50 (SD 9)
Con2: n=40, age (yr) =51 (SD 9)
Exp: aerobic; session duration not stated; 3/wk x
26 wk; intensity 50 to 60%
Con1: conventional care
Con2: self-directed progressive walking; 5/wk x
26 wk; intensity 50 to 60%
FACT-G, FACT-B, MOS SF-36
Segal38 Prostate: stages I-IV
Radiotherapy
n=121 (121 male)
Exp1: n=40, age (yr) =66 (SD 7)
Exp2: n=40, age (yr) =66 (SD 8)
Con: n=41, age (yr) =65 (SD 8)
Exp1: aerobic, resistance, stretching; 45min x 3/
wk x 24 wk; intensity 70 to 75%
Exp2: supervised resistance exercise; 2 x 8–12
reps of 10 exercises; 3/wk x 24 wk; 60 to 70% of
estimated 1RM
Con: conventional care
FACT-G, FACT-P, FACT-F,
VO2max, 1RM, DEXA scan
(percent body fat)
BDA=Beck Depression Inventory; BMI=Body mass index; DEXA=Dual-energy X-ray [2_TD$DIFF]absorptiometry; EORTC QLQ-C30=European [3_TD$DIFF]Organisation for Research and Treatment
of Cancer Quality of Life Questionnaire; FACT=Functional Assessment of Cancer Therapy, FACT-B=FACT – Breast; FACT-F= FACT – Fatigue; FACT-G=FACT – General; FACT-
P = FACT – Prostate; FACIT = Functional Assessment of Chronic Illness Therapy; FACIT-F = FACIT questionnaire for fatigue;MFSI-SF =Multidimensional Fatigue Inventory; MOS
SF-36=Medical Outcomes Study Short Form; PANAS=Positive And Negative Affect Scale; PARQ=Physical Activity Readiness Questionnaire; PFS =Piper Fatigue Scale;
RBDI = Finnishmodiﬁed version of Beck’s 13-itemdepression scale; SCFS=Schwartz Cancer Fatigue Scale; SPAQ=Scottish Physical Activity Questionnaire; SWLS=Satisfaction
with Life Scale; VO2max=maximal oxygen uptake; WHQ=Women’s Health Questionnaire; 1RM=one repetition maximum.
a Supervised physical activity interventions usually consisted of a warm-up period, aerobic training (walking, cycle ergometers and circuits), muscle strength training,
stretching exercises and a cool-down and relaxation period. The prescribed exercise intensities are reported as a percentage of maximal predicted oxygen uptake, unless
otherwise stated.
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At the 6-month follow-up, Courneya et al31 reported that the
favourable effect of aerobic exercise training on physical function-
ing was no longer statistically signiﬁcant (mean difference
5.5 points, 95% CI –1.5 to 12.4). Similarly, overall quality of life
(including fatigue) was no longer statistically signiﬁcant (mean
difference 7.6 points, 95% CI –0.1 to 15.4); however, regular
exercise was signiﬁcantly more common among the experimental
group (p = 0.017). Conversely, Mutrie et al35 stated thatmost [21_TD$DIFF]of the
beneﬁts of exercise observed at 12 weeks continued to the 6-
month follow-up. In addition, a beneﬁcial effect of exercise on the
primary outcome of breast-cancer-speciﬁc quality of life was
observed, even though it had not been signiﬁcant at the end of the
intervention.Subgroup analyses
Aerobic
Aerobic exercise was the only component of the physical
activity intervention in ﬁve trials.30–32,36,37 The effect of supervised
aerobic exercise on cancer-related fatigue was non-signiﬁcant
(SMD = –2.99, 95% CI –6.49 to 0.51) with considerable statistical
heterogeneity (p < 0.001, I2 = 100%) (Figure 4, see Figure 5 on the
eAddenda for a detailed forest plot).
Resistance
Only one trial had a group that undertook supervised resistance
training only.38 The authors analysed the effect of supervised
resistance exercise on cancer-related fatigue using a mixed-model
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Figure 2. Standardised mean difference (SMD) of the effect of supervised physical
activity on cancer-related fatigue.
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Figure 4. Standardised mean difference (SMD) of the effect of supervised aerobic
exercise on cancer-related fatigue.
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Figure 8. Standardised mean difference (SMD) of the effect of combined aerobic,
resistance and stretching exercise with supervision on cancer-related fatigue.
Research 7repeated measures analysis, which showed a beneﬁt of 4.8 points
on the FACT-Fatigue, which was statistically signiﬁcant (95% CI
1.9 to 7.7).
Aerobic and resistance
The physical activity intervention involved both aerobic and
resistance training in two studies.29,35 The effect of supervised
aerobic and resistance exercise on cancer-related fatigue was
statistically signiﬁcant (SMD = –0.41, 95% CI –0.70 to –0.13) with
no statistical heterogeneity (p = 0.47, I2 = 0%) (Figure 6, see
Figure 7 on the eAddenda for a detailed forest plot).
[(Figure_6)TD$FIG]
Study
Campbell29
Mutrie35
Pooled 
SMD (95% CI)
Random
Favours training      Favours control
-2-4 0 42
Figure 6. Standardisedmean difference (SMD) of the effect of combined aerobic and
resistance exercise with supervision on cancer-related fatigue.Aerobic, resistance and stretching
The physical activity intervention involved aerobic and resis-
tance training and stretching in four studies.28,33,34,38 This
supervised exercise regimen reduced cancer-related fatigue
signiﬁcantly (SMD = –0.67, 95% CI –1.17 to –0.17) with consider-
able statistical heterogeneity (p = 0.001, I2 = 81%) (Figure 8, see
Figure 9 on the eAddenda for a detailed forest plot).
Discussion
The present review identiﬁed a substantial amount of
information about the effects of supervised exercise on cancer-
related fatigue. These data were from trials that were rated above
average on the PEDro Scale for trials in physiotherapy.39 These
ratings were evaluated by one author, but they can be conﬁrmed
against the ratings on the PEDro website; therefore, there is
conﬁdence in the quality of the trials and in the included data.
The overall meta-analysis showed that supervised physical
activity has a favourable effect on cancer-related fatigue when
compared with conventional care. The ﬁnal analysis of the results
revealed that supervised physical activity interventions are
effective in the management of cancer-related fatigue for all types
of cancer (SMD = –1.69, 95% CI –2.99 to –0.39). The considerable
statistical heterogeneity in this meta-analysis (Figure 2) is due to
the outlying result of Saarto et al.36 This trial had the largest sample
size (n = 500) and the longest intervention program (48 weeks).
Similar beneﬁcial effects have been reported in meta-analyses of
the effect of physical activity on depression,40 fatigue9,17 and
quality of life41 among cancer survivors. The results of the present
study are in line with those published by Fong et al42 where
physical activity, with or without supervision, was positively
associated with body composition, physical functioning and
psychological outcomes, including fatigue. Nevertheless, there
still is insufﬁcient information available to deﬁne the physiological
mechanism for any potential beneﬁt of exercise in reducing fatigue
during cancer therapy or decreasing cancer risk.43–48
In contrast to other systematic reviews in this area, the trials
included in the present review all analysed participants during an
active treatment stage – the most frequent treatment was
chemotherapy (n = 1028). Oechsle et al,49 in a recent prospective
randomised pilot trial, found that supervised exercise improved
fatigue among 48 participants receiving myeloablative chemo-
therapy. The exercise was ergometer training and strength
exercises for 20 minutes each, ﬁve times a week during hospita-
lisation for chemotherapy. This trial is consistent with the ﬁnding
of the present systematic review: that supervised physical activity
improves fatigue during cancer treatment, especially in people
receiving chemotherapy; however, further trials are warranted to
strengthen this evidence.
[22_TD$DIFF]Our subgroup analysis showed that supervised aerobic exercise
did not provide signiﬁcant beneﬁts to cancer-related fatigue
(SMD = –2.99, 95% CI –6.49 to 0.51). This ﬁnding is inconsistent
Meneses-Echa´vez et al: Supervised physical exercise for cancer-related fatigue8with recent evidence suggesting that physical activity reduces
fatigue in breast cancer survivors,50 although that study analysed
data from unsupervised interventions. Interestingly, [23_TD$DIFF]our subgroup
analysis revealed that combined aerobic and resistance training
leads to a signiﬁcant reduction in fatigue in cancer survivors
(SMD = –0.41, 95% CI –0.70 to –0.13). Only one study examined the
effects of resistance training alone, although this was also beneﬁ-
cial.38 The effects of resistance exercise have not been addressed by
the American Cancer Society3 but have been examined recently in
people undergoing cancer treatment.51However, the present review
indicates that more evidence about resistance training alone would
behelpful in advising peoplewith cancerwho are undergoing cancer
therapy whether this type of training is helpful in isolation. To
understand the possible mechanisms, more information is required
regarding the effects of initial chemotherapy and radiation therapy
onmuscle satellite (progenitor) cells that are activated to proliferate
in response to resistance exercise.9,51
A further and interesting ﬁnding of the present review was the
positive effect of combined aerobic, resistance and stretching
exercise with supervision for reducing fatigue in people who have
been diagnosed with cancer. The stretching training consisted of
slow muscle movements that had neither aerobic nor muscle
resistance components.
It is not clear whether previously sedentary people can or will
adhere to an exercise program, and, if they cannot, whether the
amount of exercise they do engage inwill still be of beneﬁt in terms
of symptom relief (ie, anxiety, depression, lack of sleep, mood
change) and reduction of the risk of adverse events.52
The present review had some limitations. Publication bias may
have been present, but it was not possible to test for it due to the
small number of included studies. [24_TD$DIFF]Also, heterogeneity was present
in most of the meta-analyses. This may be due to the range of
sample sizes, the diverse exercise regimens (in terms of length,
duration and intensity) evaluated, and thewide variety in outcome
measurement tools used in the included studies.
While further research is necessary in order to determine the
optimal exercise program for people with cancer, the results of
the present review indicate that physiotherapists should conduct
careful pre-screening and prescribe appropriate physical activity
programs, adjusting for each person [ 25 _ T D$ D I FF ]’s speciﬁc variables, such as
physiological responses and physical disturbances related to the
cancer and its treatment. The ﬁndings of the present systematic
review reinforce the value of physiotherapy supervision in
clinical practice for people with cancer and reinforce the concept
that physical activity reduces cancer-related fatigue in this
population.What is already known on this topic: Supervised physical
activity improves muscle mass, muscle function and quality of
life among people who have been diagnosed with cancer. The
optimal exercise program for adults who have been diagnosed
with cancer has not yet been established.
What this studyadds: In general, supervisedphysical activity
reduces fatigue among people who have been diagnosed with
cancer. Specifically, combined aerobic and resistance training
with or without stretching are effective exercise regimens for
reducing cancer-related fatigue. Supervised resistance exer-
cise alone appears to be beneficial, based on one study.
Current evidence does not make it clear whether supervised
aerobic exercise alone or supervised stretching alone are
beneficial in this population.eAddenda: Figures 3, 5, 7 and 9 and Appendix 1 can be found
online at doi:10.1016/j.jphys.2014.08.019.
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